Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Ironwood Pharmaceuticals Inc (IRWD)

220 + Investors. Track Smart Money conviction in IRWD. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%

220+

Inst. Holders

Hedge Fund Ownership: IRWD

How many hedge funds hold IRWD — quarterly history vs. share price
Quarterly hedge fund ownership of IRWD vs. share price

Market Analysis: IRWD

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: IRWD

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Loading signal freshness…
Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

22 top-rated funds 0 high-conviction
Consensus
5.9
/ 10
breadth
×
Elite
1.0
/ 10
conviction
Hedge Fund Positioning: IRWD
220 + Investors

Track Smart Money conviction in IRWD. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 220 196 12.24%
13F Shares 174M 166M 4.98%
Total Value $584M $558M 4.6%
New Positions 52 57 -5
Increased Positions 83 63 +20
Closed Positions 28 28 -
Reduced Positions 56 47 +9
Total Calls 5 4 25.0%
Total Puts 4 2 100.0%
PUT/CALL Ratio 0.8 0.5 Neutral

Statistics: IRWD

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

220 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in IRWD. Verified SEC 13F-HR filings.

QUARTER:
Top 25 IRWD holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Sarissa Capital Management LP 20.46% 9,188,635 $32.3M
2 CM Management, LLC 1.03% 350,000 $1.2M
3 Armistice Capital, LLC 0.94% 15,028,000 $52.7M
4 Range Financial Group LLC 0.51% 433,256 $1.5M
5 Integrated Quantitative Investments LLC 0.35% 552,104 $1.9M
6 Harvest Investment Services, LLC 0.16% 241,881 $849K
7 Inspire Investing, LLC 0.15% 509,941 $1.8M
8 Optimist Retirement Group LLC 0.15% 94,831 $333K
9 Globeflex Capital L P 0.14% 259,809 $912K
10 Hillsdale Investment Management Inc. 0.12% 1,236,628 $4.3M
11 SmartHarvest Portfolios, LLC 0.11% 75,462 $265K
12 nVerses Capital, LLC 0.10% 32,554 $114K
13 Virtus Advisers, LLC 0.09% 58,000 $204K
14 EntryPoint Capital, LLC 0.09% 86,874 $305K
15 Virtus Investment Advisers, LLC 0.07% 76,169 $267K
16 Jacobs Levy Equity Management, Inc 0.05% 3,632,477 $12.7M
17 State of Wyoming 0.05% 128,175 $450K
18 Legato Capital Management LLC 0.05% 156,059 $548K
19 Scientech Research LLC 0.05% 15,917 $56K
20 Renaissance Technologies LLC 0.04% 8,061,073 $28.3M
21 Wedge Capital Management L L P/Nc 0.04% 540,492 $1.9M
22 Bridgeway Capital Management, LLC 0.03% 440,493 $1.5M
23 WINTON GROUP Ltd 0.03% 241,746 $849K
24 MQS Management LLC 0.03% 11,451 $40K
25 Essential Partners LLC 0.03% 22,102 $78K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Ironwood Pharmaceuticals Inc (IRWD)

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →